首页> 外文会议>International Biodetection Technologies Conference >Biothreat and Pathogen Diagnostics: Current Technology, Regulations, and Challenges with Accelerated Assay Development - (PPT)
【24h】

Biothreat and Pathogen Diagnostics: Current Technology, Regulations, and Challenges with Accelerated Assay Development - (PPT)

机译:生物重组和病原体诊断:当前的技术,法规和加速试验发展的挑战 - (PPT)

获取原文

摘要

Overview: 1. FDA - wide initiative: Coordinates Medical Countermeasure (MCM) development, public health preparedness, response efforts; 2. MCM products are FDA regulated; 3. U.S. Department of Health and Human Services (HHS) & Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) coordinate MCM-related efforts across HHS/geographically diverse USG interagency partners.
机译:概述:1。FDA - 广泛倡议:协调医疗对策(MCM)发展,公共卫生准备,反应努力; 2. MCM产品是FDA规范; 3.美国卫生和人类服务部(HHS)和公共卫生应急医疗对策企业(PHEMCE)在HHS /地理上不同的USG互动伙伴中协调MCM相关的努力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号